| Emerging strategies to overcome resistance to third-generation EGFR inhibitors K Shi, G Wang, J Pei, J Zhang, J Wang, L Ouyang, Y Wang, W Li Journal of Hematology & Oncology 15 (1), 94, 2022 | 98 | 2022 |
| DYRK1A inhibitors for disease therapy: Current status and perspectives T Liu, Y Wang, J Wang, C Ren, H Chen, J Zhang European journal of medicinal chemistry 229, 114062, 2022 | 77 | 2022 |
| Recent advances in Alzheimer’s disease: Mechanisms, clinical trials and new drug development strategies J Zhang, Y Zhang, J Wang, Y Xia, J Zhang, L Chen Signal transduction and targeted therapy 9 (1), 211, 2024 | 67 | 2024 |
| Molecular interactions at the colchicine binding site in tubulin: An X-ray crystallography perspective J Wang, DD Miller, W Li Drug discovery today 27 (3), 759-776, 2022 | 64 | 2022 |
| Targeting EZH2 for cancer therapy: From current progress to novel strategies J Zeng, J Zhang, Y Sun, J Wang, C Ren, S Banerjee, L Ouyang, Y Wang European journal of medicinal chemistry 238, 114419, 2022 | 60 | 2022 |
| Polo-like kinase 1 inhibitors in human cancer therapy: development and therapeutic potential J Zhang, L Zhang, J Wang, L Ouyang, Y Wang Journal of medicinal chemistry 65 (15), 10133-10160, 2022 | 58 | 2022 |
| CD25: A potential tumor therapeutic target Y Peng, Y Tao, Y Zhang, J Wang, J Yang, Y Wang International Journal of Cancer 152 (7), 1290-1303, 2023 | 49 | 2023 |
| Targeting ferroptosis: paving new roads for drug design and discovery Y Gu, Y Li, J Wang, L Zhang, J Zhang, Y Wang European Journal of Medicinal Chemistry 247, 115015, 2023 | 47 | 2023 |
| Progress and challenges in targeted protein degradation for neurodegenerative disease therapy Y Fang, J Wang, M Zhao, Q Zheng, C Ren, Y Wang, J Zhang Journal of Medicinal Chemistry 65 (17), 11454-11477, 2022 | 47 | 2022 |
| Strategies of targeting CK2 in drug discovery: challenges, opportunities, and emerging prospects Y Chen, Y Wang, J Wang, Z Zhou, S Cao, J Zhang Journal of Medicinal Chemistry 66 (4), 2257-2281, 2023 | 41 | 2023 |
| Targeting bromodomain-selective inhibitors of BET proteins in drug discovery and development J Chen, P Tang, Y Wang, J Wang, C Yang, Y Li, G Yang, F Wu, J Zhang, ... Journal of medicinal chemistry 65 (7), 5184-5211, 2022 | 37 | 2022 |
| Recent advances of human dihydroorotate dehydrogenase inhibitors for cancer therapy: Current development and future perspectives L Zhang, J Zhang, J Wang, C Ren, P Tang, L Ouyang, Y Wang European journal of medicinal chemistry 232, 114176, 2022 | 33 | 2022 |
| Development of inhibitors targeting glycogen synthase kinase-3β for human diseases: Strategies to improve selectivity J Wei, J Wang, J Zhang, J Yang, G Wang, Y Wang European journal of medicinal chemistry 236, 114301, 2022 | 29 | 2022 |
| Dual-target inhibitors of poly (ADP-ribose) polymerase-1 for cancer therapy: Advances, challenges, and opportunities X Hu, J Zhang, Y Zhang, F Jiao, J Wang, H Chen, L Ouyang, Y Wang European Journal of Medicinal Chemistry 230, 114094, 2022 | 27 | 2022 |
| Advances in epilepsy: mechanisms, clinical trials, and drug therapies T Hu, J Zhang, J Wang, L Sha, Y Xia, TC Ortyl, X Tian, L Chen Journal of medicinal chemistry 66 (7), 4434-4467, 2023 | 24 | 2023 |
| Preparation and evaluation of liposomes co-loaded with doxorubicin, phospholipase D inhibitor 5-fluoro-2-indolyl deschlorohalopemide (FIPI) and D-alpha tocopheryl acid … M Song, J Wang, J Lei, G Peng, W Zhang, Y Zhang, M Yin, J Li, Y Liu, ... Nanoscale Research Letters 14, 1-13, 2019 | 20 | 2019 |
| Small-molecule receptor-interacting protein 1 (RIP1) inhibitors as therapeutic agents for multifaceted diseases: current medicinal chemistry insights and emerging opportunities K Shi, J Zhang, E Zhou, J Wang, Y Wang Journal of Medicinal Chemistry 65 (22), 14971-14999, 2022 | 19 | 2022 |
| Small-molecule modulators targeting toll-like receptors for potential anticancer therapeutics J Wang, J Zhang, J Wang, X Hu, L Ouyang, Y Wang Journal of Medicinal Chemistry 66 (10), 6437-6462, 2023 | 18 | 2023 |
| Targeting SARS-CoV-2 entry processes: The promising potential and future of host-targeted small-molecule inhibitors A Wu, K Shi, J Wang, R Zhang, Y Wang European Journal of Medicinal Chemistry 263, 115923, 2024 | 17 | 2024 |
| Transient receptor potential ankyrin 1 (TRPA1) modulators: Recent update and future perspective Z Hu, Y Zhang, W Yu, J Li, J Yao, J Zhang, J Wang, C Wang European Journal of Medicinal Chemistry 257, 115392, 2023 | 16 | 2023 |
Hao ChenUniversity of Tennessee Health Science CenterBestätigte E-Mail-Adresse bei uthsc.edu